| 产品名称： | Aspergillus fischeri var. brasiliensis Karwowski et al., anamorph |
|---|---|
| 商品货号： | TS173675 |
| Strain Designations： | AB 1826M-35 NRRL 18896 |
| Application： | produces 5-N-acetylardeemin |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 325: Malt extract agar (Blakeslees formula) |
| Growth Conditions： | Temperature: 37.0°C |
| Sequenced Data： | No DNA sequencing was performed in house on this product.
|
| Name of Depositor： | Abbott Labs. |
| Special Collection： | NCRR Contract |
| Chain of Custody： | ATCC < |
| Isolation： | soil, Brazil |
| References： | Kadam SK, et al. Multiple drug resistance-attenuating compounds. US Patent 5,284,947 dated Feb 8 1994 Karwowski JP, et al. 5-N-acetylardeemin, a novel heterocyclic compound which reverses multiple drug resistance in tumor cells. I. Taxonomy and fermentation of the producing organism and biological activity. J. Antibiot. 46: 374-379, 1993. PubMed: 8478255 Hochlowski JE, et al. 5-N-acetylardeemin, a novel heterocyclic compound which reverses multiple drug resistance in tumor cells. II. Isolation and elucidation of the structure of 5-N-acetylardeemin and two congeners. J. Antibiot. 46: 380-386, 1993. PubMed: 8478256 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Aspergillus fischeri var. brasiliensis Karwowski et al., anamorph |
|---|---|
| 商品货号： | TS173675 |
| Strain Designations： | AB 1826M-35 NRRL 18896 |
| Application： | produces 5-N-acetylardeemin |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 325: Malt extract agar (Blakeslees formula) |
| Growth Conditions： | Temperature: 37.0°C |
| Sequenced Data： | No DNA sequencing was performed in house on this product.
|
| Name of Depositor： | Abbott Labs. |
| Special Collection： | NCRR Contract |
| Chain of Custody： | ATCC < |
| Isolation： | soil, Brazil |
| References： | Kadam SK, et al. Multiple drug resistance-attenuating compounds. US Patent 5,284,947 dated Feb 8 1994 Karwowski JP, et al. 5-N-acetylardeemin, a novel heterocyclic compound which reverses multiple drug resistance in tumor cells. I. Taxonomy and fermentation of the producing organism and biological activity. J. Antibiot. 46: 374-379, 1993. PubMed: 8478255 Hochlowski JE, et al. 5-N-acetylardeemin, a novel heterocyclic compound which reverses multiple drug resistance in tumor cells. II. Isolation and elucidation of the structure of 5-N-acetylardeemin and two congeners. J. Antibiot. 46: 380-386, 1993. PubMed: 8478256 |
